Nasus Pharma Ltd (NSRX) (CIK 0002029039) UPLOAD
An UPLOAD letter is the SEC's written comment to the company during a filing review. SEC staff flag accounting issues, ICFR weaknesses, segment-reporting disputes, and revenue-recognition concerns here. Released to EDGAR 20 days after the SEC closes its review.
Key facts
- Accession number
- 0000000000-26-002335
- Form
- UPLOAD
- Filer
- Nasus Pharma Ltd (NSRX) (CIK 0002029039)
- CIK
- 0002029039
- Ticker
- NSRX
- Filed
- 2026-03-06
- SEC file number
- 333-293950
- SIC industry
- 2834
- HQ
- Tel Aviv - Yafo, L3
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/2029039/000000000026002335/filename1.pdf
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer